Overview
- 6 inspections across 5 sites are on record.
- 50 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-05-31.
At a glance
Inspections
6
Sites
5
Observations
50
Career since
Jul 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Hisamitsu Pharmaceutical Co., Inc. | 31 May 2019 | Human Drugs | View 483 → |
| Noven Pharmaceuticals, Inc. | 26 Jan 2018 | Human Drugs | On file |
| Corium Innovations, Inc. | 27 Oct 2017 | Human Drugs | View 483 → |
| Bayer de Mexico, S.A. de C.V. | 15 Jul 2016 | Human Drugs | View 483 → |
| Fareva Richmond, Inc. | 1 Jul 2016 | Human Drugs | View 483 → |
Sites inspected
Hisamitsu Pharmaceutical Co., Inc.Tosu, Japan1 insp.
Noven Pharmaceuticals, Inc.Miami, United States1 insp.
Corium Innovations, Inc.Grand Rapids, United States1 insp.
Bayer de Mexico, S.A. de C.V.Ixtaczoquitlan, Mexico1 insp.
Fareva Richmond, Inc.Henrico, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Saundrea A Munroe1 shared
Noreen Muniz1 shared
Charles L Zhou1 shared
Matthew B Casale1 shared
Jingbo Xiao1 shared
Eric L Dong1 shared
Santos E Camara1 shared
Marcus A Ray1 shared
Sarah Ibrahim1 shared
Richard A Lyght1 shared
Full investigator report
Get the verbatim findings behind Caroline Strasinger's 50 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site